TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | -1 | -1 | -4 | 13 | -4 | 0 | 1 |
| S | %wins | 75 | 75 | 100 | 0 | 100 | 70 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/27/16 16:12 | 9/23/16 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Albitar Maher | FL | O | Chief Me | S.d | -24 | 8.40 | 2 | -3 | -2 | 124 | I | 55 | 34 | 26 | 5 | 1 | 4 | 2 | 0 | -1 | -1 | -11 | 9 | -7 | |
9/22/16 17:48 | 9/20/16 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Albitar Maher | FL | O | Chief Me | S.d | -863 | 8.20 | 2 | -105 | -38 | 169 | D | 50 | 23 | 29 | -3 | 1 | 2 | 0 | 1 | 1 | -2 | -5 | 15 | -8 | |
9/13/16 18:15 | 9/9/16 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Albitar Maher | FL | O | Chief Me | S.dm | -494 | 8.23 | 2 | -60 | -15 | 334 | D | 41 | 25 | 18 | 1 | -4 | -1 | 2 | 2 | -2 | 1 | 0 | 17 | -2 | |
8/23/16 16:28 | 8/19/16 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Albitar Maher | FL | O | Chief Me | S.d | -3,045 | 8.23 | 3 | -370 | -56 | 292 | D | 54 | 44 | 41 | -6 | -9 | -1 | 2 | 2 | -2 | -2 | -1 | 11 | 0 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |